Global Chagas Disease Coalition

The Global Chagas Disease Coalition is an alliance of partners who have joined forces to promote access to diagnosis and treatment for patients with Chagas disease and to stimulate innovation in this field and the development of new tools to fight the disease.

Although international guidelines recommend that patients with Chagas disease should be treated, only 1% of those affected currently have access to treatment. This deplorable situation is the reason why the mobilization of efforts to increase access to treatment is so urgent, and the Coalition's aim is to play a central role in driving the agenda and achieving this goal.

In addition to its five founding members —ISGlobal, Drugs for Neglected Diseases initiative (DNDi), Fundación Mundo Sano, CEADES and the Sabin Vaccine Institute—the Coalition hopes to incorporate more institutions interested in joining this alliance against Chagas disease and  has recently welcomed two new members—the Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center and the Nhepacha network. 

Learn More

Global Chagas Coalition Declaration



New Tools for the Diagnosis and Evaluation of Chagas Disease

Other projects

See Past Projects


New Tools for the Diagnosis and Evaluation of Chagas Disease

Control of Leishmaniasis. From bench to bedside and community


Grup de recerca en patología importada i malaties emergents i re-emergents


Antigen-specific immunological biomarkers associated to control of infection by T. cruzi.


Model and Tool for designing strategies to scale up Chagas Disease care


Towards the interruption of transmission of soil-transmitted helminths


New chemotherapy regimens and biomarkers for Chagas Disease


Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.

ChagasLAMP (GHIT G2020-203)

Field validation of Trypanosoma cruzi-LAMP: a molecular point-of-care test for the control of congenital Chagas disease


Enhanced and equitable coverage of COVID-19 testing and treatment in Bolivia and Paraguay